News

News
Partner news

OrthoSpin Ltd. Raises up to US$5 Million in Series B Financing

Read full story
Partner news

FDA Clearance Brings RefleXion Closer to Expanding Cancer Treatment Market

Read full story
Other news

Third Pole Therapeutics Announces Inhaled Nitric Oxide Strategic Collaboration with Actelion, a Janssen Pharmaceutical Company of Johnson & Johnson

Read full story
JNJ Press releases

Big Pharma’s Billion-Dollar Scramble to Invest in Start-ups to Fuel Innovation

Read full story
Partner news

Protagonist Therapeutics Discontinues Phase 2b PROPEL Trial of PTG-100 for the Treatment of Ulcerative Colitis following Interim Analysis

Read full story
JNJ Press releases

Helsinn Group announces agreement to acquire worldwide rights to Valchlor®/Ledaga® - an approved and marketed alkylating agent for the topical treatment of mycosis fungoides‐type cutaneous T‐cell lymphoma, a rare type of skin cancer

Read full story
In the media

What J&J gets out of JLABS incubators

Read full story
In the media

Special Report Mental health: Brain scans and DNA tests personalise mental healthcare

Read full story
JNJ Press releases

Johnson & Johnson Innovation Launches Advancing the Safe Use of Healthcare Products QuickFire Challenge

Read full story
JNJ Press releases

Johnson & Johnson Innovation launches Singapore QuickFire Challenge Competition in collaboration with ETPL and SMART to accelerate solutions for diabetes and other metabolic diseases

Read full story
Partner news

Bristol-Myers Squibb to Acquire Padlock Therapeutics, Inc.

Read full story
JNJ Press releases

Johnson & Johnson Innovation Launches a New Company Incubation Model Located at the Janssen Research & Development Campus in Beerse, Belgium

Read full story
JNJ Press releases

Bioqube ventures launches specialist investment firm and announces collaboration with Johnson & Johnson Innovation, JLINX

Read full story
JNJ Press releases

Johnson & Johnson Innovation Launches JLINX: A New Company Incubation Model Located at the Janssen Campus in Belgium

Read full story
JNJ Press releases

Johnson & Johnson Innovation Launches JLINX: A New Company Incubation Model Located at the Janssen Campus in Belgium

Read full story